These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8281969)

  • 1. Origin and mechanisms of heart failure in hypertensive patients: left ventricular remodelling in hypertensive heart disease.
    Dubus I; Samuel JL; Swynghedauw B
    Eur Heart J; 1993 Nov; 14 Suppl J():76-81. PubMed ID: 8281969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The biological basis of modified myocardial function in hypertensive cardiopathy.
    Swynghedauw B; Carré F
    Acta Cardiol; 1991; 46(2):167-77. PubMed ID: 2048364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Impact of arterial hypertension on the heart].
    Herpin D
    Rev Prat; 1999 Mar; 49(5):491-4. PubMed ID: 10358398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ventricular arrhythmias and arterial hypertension].
    Dorobantu M; Galinier M; Bounhoure JP
    Ann Cardiol Angeiol (Paris); 1996 May; 45(5):291-5. PubMed ID: 8763649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiac failure in hypertensive cardiopathy].
    Verdecchia P
    Ital Heart J; 2000 Jun; 1 Suppl 2():72-7. PubMed ID: 10905132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac hypertrophy and failure--a disease of adaptation. Modifications in membrane proteins provide a molecular basis for arrhythmogenicity.
    Moalic JM; Charlemagne D; Mansier P; Chevalier B; Swynghedauw B
    Circulation; 1993 May; 87(5 Suppl):IV21-6. PubMed ID: 8485830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Physiopathology of cardiac insufficiency. Biological factors of adaptation and disadaptation of the heart to chronic mechanical overload].
    Swynghedauw B
    Schweiz Med Wochenschr; 1995 Feb; 125(7):288-93. PubMed ID: 7878407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease.
    Gradman AH; Alfayoumi F
    Prog Cardiovasc Dis; 2006; 48(5):326-41. PubMed ID: 16627048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remodeling of the heart (membrane proteins and collagen) in hypertensive cardiopathy.
    Sainte Beuve C; Leclercq C; Rannou F; Oliviero P; Mansier P; Chevalier B; Swynghedauw B; Charlemagne D
    Kidney Int Suppl; 1992 Jun; 37():S45-50. PubMed ID: 1385839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of hypertension in the pathogenesis of heart failure. A clinical mechanistic overview.
    Vasan RS; Levy D
    Arch Intern Med; 1996 Sep; 156(16):1789-96. PubMed ID: 8790072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional myocardial ischaemia and diastolic dysfunction in hypertensive heart disease.
    López Sendón J
    Eur Heart J; 1993 Nov; 14 Suppl J():110-3. PubMed ID: 8281954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
    Gao S; Long CL; Wang RH; Wang H
    Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The primary and secondary prevention of hypertensive cardiopathy].
    Agabiti-Rosei E; Muiesan ML
    Ital Heart J; 2000 Jun; 1 Suppl 2():59-66. PubMed ID: 10905130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When calcium turns arrhythmogenic: intracellular calcium handling during the development of hypertrophy and heart failure.
    Zaugg CE; Buser PT
    Croat Med J; 2001 Feb; 42(1):24-32. PubMed ID: 11172652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone, acromegaly, and heart failure: an intricate triangulation.
    Saccà L; Napoli R; Cittadini A
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):660-71. PubMed ID: 14974906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left atrial systolic force in hypertensive patients with left ventricular hypertrophy: the LIFE study.
    Chinali M; de Simone G; Wachtell K; Gerdts E; Gardin JM; Boman K; Nieminen MS; Papademetriou V; Dahlöf B; Devereux RB
    J Hypertens; 2008 Jul; 26(7):1472-6. PubMed ID: 18551025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac consequences of hypertension in hemodialysis patients.
    Zoccali C; Benedetto FA; Tripepi G; Mallamaci F
    Semin Dial; 2004; 17(4):299-303. PubMed ID: 15250922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Left-ventricular hypertrophy as a cardiac risk factor: role of the renin-angiotensin-aldosterone system].
    Erne P
    Praxis (Bern 1994); 1996 Feb; 85(8):227-33. PubMed ID: 8701189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertension and heart failure: a dysfunction of systole, diastole or both?
    Yip GW; Fung JW; Tan YT; Sanderson JE
    J Hum Hypertens; 2009 May; 23(5):295-306. PubMed ID: 19037230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular hypertrophy and coronary microcirculation in hypertensive heart disease.
    Strauer BE; Schwartzkopff B
    Blood Press Suppl; 1997; 2():6-12. PubMed ID: 9495619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.